These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2150352)

  • 1. [Studies on the abnormal response of pituitary somatotropin to dopaminergic drugs in patients with acromegaly].
    Shi YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):168-72. PubMed ID: 2150352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
    Tallo D; Malarkey WB
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1278-84. PubMed ID: 7298804
    [No Abstract]   [Full Text] [Related]  

  • 8. Somatotroph responsiveness to low dose dopamine infusion in normal subjects and acromegalic patients.
    Serri O
    Neuroendocrinology; 1986; 42(6):475-80. PubMed ID: 3010156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
    Müller EE; Salerno F; Cocchi D; Locatelli V; Panerai AE
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):645-56. PubMed ID: 119594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.
    Oppizzi G; Liuzzi A; Chiodini P; Dallabonzana D; Spelta B; Silvestrini F; Borghi G; Tonon C
    J Clin Endocrinol Metab; 1984 Jun; 58(6):988-92. PubMed ID: 6725515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulsar analysis of the 24-hour secretion of GH in normal subjects, in acromegalics and in patients with non-secreting and prolactin-secreting pituitary adenoma].
    Morosini P; Sarzani R; Arnaldi G
    Recenti Prog Med; 1988 Oct; 79(10):400-6. PubMed ID: 3247506
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients.
    Verde G; Oppizzi G; Colussi G; Cremascoli G; Botalla L; Müller EE; Silvestrini F; Chiodini PG; Liuzzi A
    Clin Endocrinol (Oxf); 1976 Jul; 5(4):419-23. PubMed ID: 971548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effect of dopamine on growth hormone (GH) release from human GH-secreting pituitary adenomas.
    Spada A; Sartorio A; Bassetti M; Pezzo G; Giannattasio G
    J Clin Endocrinol Metab; 1982 Oct; 55(4):734-40. PubMed ID: 7107817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.
    Ferrari C; Rampini P; Paracchi A; Boghen M; Mailland F
    Eur J Clin Pharmacol; 1985; 27(6):707-11. PubMed ID: 3921384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
    Delitala G; Masala A; Alagna S; Devilla L; Lotti G
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1382-6. PubMed ID: 1002821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic inhibition of growth hormone and prolactin release during continuous in vitro perifusion of normal and adenomatous human pituitary.
    Lawton NF; Evans AJ; Weller RO
    J Neurol Sci; 1981 Feb; 49(2):229-39. PubMed ID: 7217982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.